The initiative's software was supposed to help suggest treatment options for cancer, but the program has stumbled in the past few years as it tries to integrate into the health system. Deborah DiSanzo will be succeeded by John Kelly, the senior vice president for Cognitive Solutions and IBM Research, who will step into DiSanzo’s role in an acting capacity.
from Kaiser Health News https://ift.tt/2R5eqxO
October 22, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Pain Hits After Surgery When A Doctor’s Daughter Is Stunned By $17,850 Urine Test… Read More
In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation… Read More
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’… Read More
‘Bill Of The Month’: A College Student’s $17,850 Drug Test… Read More
Podcast: KHN’s ‘What The Health?’ What Do The Budget, Idaho And FDA Chief Scott Gottlieb Have In Common?… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment